Review Article
No access
Published Online: 20 October 2020

CRISPR-Cas Activators for Engineering Gene Expression in Higher Eukaryotes

Publication: The CRISPR Journal
Volume 3, Issue Number 5

Abstract

CRISPR-Cas-based transcriptional activators allow genetic engineers to specifically induce expression of one or many target genes in trans. Here we review the many design variations of these versatile tools and compare their effectiveness in different eukaryotic systems. Lastly, we highlight several applications of programmable transcriptional activation to interrogate and engineer complex biological processes.

Get full access to this article

View all available purchase options and get full access to this article.

Authorship Confirmation Statement

All authors contributed to the writing and revision of the article. The final version of the article was approved by all authors.

References

1. Adli M. The CRISPR tool kit for genome editing and beyond. Nat Commun. 2018;9:1911.
2. Garneau JE, Dupuis ME, Villion M, et al. The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature. 2010;468:67–71.
3. Gasiunas G, Barrangou R, Horvath P, et al. Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc Natl Acad Sci U S A. 2012;109:E2579–E2586.
4. Jinek M, Chylinski K, Fonfara I, et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science. 2012;337:816–821.
5. Qi LS, Larson MH, Gilbert LA, et al. Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell. 2013;152:1173–1183.
6. Mali P, Aach J, Stranges PB, et al. CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering. Nat Biotechnol. 2013;31:833–838.
7. Green MR. Eukaryotic transcription activation: Right on target. Mol Cell. 2005;18:399–402.
8. Petrenko N, Jin Y, Dong L, et al. Requirements for RNA polymerase II preinitiation complex formation in vivo. Elife. 2019;8:e43654.
9. Allen BL, Taatjes DJ. The Mediator complex: A central integrator of transcription. Nat Rev Mol Cell Biol. 2015;16:155–166.
10. Boija A, Klein IA, Sabari BR, et al. Transcription factors activate genes through the phase-separation capacity of their activation domains. Cell. 2018;175:1842–1855 e1816.
11. Sadowski I, Ma J, Triezenberg S, et al. GAL4-VP16 is an unusually potent transcriptional activator. Nature. 1988;335:563–564.
12. Beerli RR, Segal DJ, Dreier B, et al. Toward controlling gene expression at will: Specific regulation of the erbB-2/HER-2 promoter by using polydactyl zinc finger proteins constructed from modular building blocks. Proc Natl Acad Sci U S A. 1998;95:14628–14633.
13. Chavez A, Scheiman J, Vora S, et al. Highly efficient Cas9-mediated transcriptional programming. Nat Methods. 2015;12:326–328.
14. Li Z, Zhang D, Xiong X, et al. A potent Cas9-derived gene activator for plant and mammalian cells. Nat Plants. 2017;3:930–936.
15. Schmitz ML, Baeuerle PA. The p65 subunit is responsible for the strong transcription activating potential of NF-kappa B. EMBO J. 1991;10:3805–3817.
16. Hardwick JM, Tse L, Applegren N, et al. The Epstein-Barr virus R transactivator (Rta) contains a complex, potent activation domain with properties different from those of VP16. J Virol. 1992;66:5500–5508.
17. Green M, Schuetz TJ, Sullivan EK, et al. A heat shock-responsive domain of human HSF1 that regulates transcription activation domain function. Mol Cell Biol. 1995;15:3354–3362.
18. Stockinger EJ, Gilmour SJ, Thomashow MF. Arabidopsis thaliana CBF1 encodes an AP2 domain-containing transcriptional activator that binds to the C-repeat/DRE, a cis-acting DNA regulatory element that stimulates transcription in response to low temperature and water deficit. Proc Natl Acad Sci U S A. 1997;94:1035–1040.
19. Tiwari SB, Belachew A, Ma SF, et al. The EDLL motif: A potent plant transcriptional activation domain from AP2/ERF transcription factors. Plant J. 2012;70:855–865.
20. Young JK, Gasior SL, Jones S, et al. The repurposing of type I-E CRISPR-Cascade for gene activation in plants. Commun Biol. 2019;2:383.
21. Zhu W, Yang B, Chittoor JM, et al. AvrXa10 contains an acidic transcriptional activation domain in the functionally conserved C terminus. Mol Plant Microbe Interact. 1998;11:824–832.
22. Sigler PB. Transcriptional activation. Acid blobs and negative noodles. Nature. 1988;333:210–212.
23. Babu MM. The contribution of intrinsically disordered regions to protein function, cellular complexity, and human disease. Biochem Soc Trans. 2016;44:1185–1200.
24. Kwon I, Kato M, Xiang S, et al. Phosphorylation-regulated binding of RNA polymerase II to fibrous polymers of low-complexity domains. Cell. 2013;155:1049–1060.
25. Boehning M, Dugast-Darzacq C, Rankovic M, et al. RNA polymerase II clustering through carboxy-terminal domain phase separation. Nat Struct Mol Biol. 2018;25:833–840.
26. Cheng AW, Wang H, Yang H, et al. Multiplexed activation of endogenous genes by CRISPR-on, an RNA-guided transcriptional activator system. Cell Res. 2013;23:1163–1171.
27. Farzadfard F, Perli SD, Lu TK. Tunable and multifunctional eukaryotic transcription factors based on CRISPR/Cas. ACS Synth Biol. 2013;2:604–613.
28. Gilbert LA, Larson MH, Morsut L, et al. CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell. 2013;154:442–451.
29. Kearns NA, Genga RM, Enuameh MS, et al. Cas9 effector-mediated regulation of transcription and differentiation in human pluripotent stem cells. Development. 2014;141:219–223.
30. Maeder ML, Linder SJ, Cascio VM, et al. CRISPR RNA-guided activation of endogenous human genes. Nat Methods. 2013;10:977–979.
31. Perez-Pinera P, Kocak DD, Vockley CM, et al. RNA-guided gene activation by CRISPR-Cas9-based transcription factors. Nat Methods. 2013;10:973–976.
32. Piatek A, Ali Z, Baazim H, et al. RNA-guided transcriptional regulation in planta via synthetic dCas9-based transcription factors. Plant Biotechnol J. 2015;13:578–589.
33. Konermann S, Brigham MD, Trevino AE, et al. Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. Nature. 2015;517:583–588.
34. Zalatan JG, Lee ME, Almeida R, et al. Engineering complex synthetic transcriptional programs with CRISPR RNA scaffolds. Cell. 2015;160:339–350.
35. Tanenbaum ME, Gilbert LA, Qi LS, et al. A protein-tagging system for signal amplification in gene expression and fluorescence imaging. Cell. 2014;159:635–646.
36. Kunii A, Hara Y, Takenaga M, et al. Three-component repurposed technology for enhanced expression: Highly accumulable transcriptional activators via branched tag arrays. CRISPR J. 2018;1:337–347.
37. Zetsche B, Gootenberg JS, Abudayyeh OO, et al. Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell. 2015;163:759–771.
38. Zhang X, Wang J, Cheng Q, et al. Multiplex gene regulation by CRISPR-ddCpf1. Cell Discov. 2017;3:17018.
39. Tak YE, Kleinstiver BP, Nunez JK, et al. Inducible and multiplex gene regulation using CRISPR-Cpf1-based transcription factors. Nat Methods. 2017;14:1163–1166.
40. Zhang X, Xu L, Fan R, et al. Genetic editing and interrogation with Cpf1 and caged truncated pre-tRNA-like crRNA in mammalian cells. Cell Discov. 2018;4:36.
41. Zhang X, Wang W, Shan L, et al. Gene activation in human cells using CRISPR/Cpf1-p300 and CRISPR/Cpf1-SunTag systems. Protein Cell. 2018;9:380–383.
42. Nihongaki Y, Otabe T, Ueda Y, et al. A split CRISPR-Cpf1 platform for inducible genome editing and gene activation. Nat Chem Biol. 2019;15:882–888.
43. Kim D, Kim J, Hur JK, et al. Genome-wide analysis reveals specificities of Cpf1 endonucleases in human cells. Nat Biotechnol. 2016;34:863–868.
44. Kleinstiver BP, Tsai SQ, Prew MS, et al. Genome-wide specificities of CRISPR-Cas Cpf1 nucleases in human cells. Nat Biotechnol. 2016;34:869–874.
45. Singh D, Mallon J, Poddar A, et al. Real-time observation of DNA target interrogation and product release by the RNA-guided endonuclease CRISPR Cpf1 (Cas12a). Proc Natl Acad Sci U S A. 2018;115:5444–5449.
46. Zetsche B, Heidenreich M, Mohanraju P, et al. Multiplex gene editing by CRISPR-Cpf1 using a single crRNA array. Nat Biotechnol. 2017;35:31–34.
47. Makarova KS, Wolf YI, Alkhnbashi OS, et al. An updated evolutionary classification of CRISPR-Cas systems. Nat Rev Microbiol. 2015;13:722–736.
48. Anderson GM, Freytag SO. Synergistic activation of a human promoter in vivo by transcription factor Sp1. Mol Cell Biol. 1991;11:1935–1943.
49. Carey M, Lin YS, Green MR, et al. A mechanism for synergistic activation of a mammalian gene by GAL4 derivatives. Nature. 1990;345:361–364.
50. Pettersson M, Schaffner W. Synergistic activation of transcription by multiple binding sites for NF-kappa B even in absence of co-operative factor binding to DNA. J Mol Biol. 1990;214:373–380.
51. Perez-Pinera P, Ousterout DG, Brunger JM, et al. Synergistic and tunable human gene activation by combinations of synthetic transcription factors. Nat Methods. 2013;10:239–242.
52. Gilbert LA, Horlbeck MA, Adamson B, et al. Genome-scale CRISPR-mediated control of gene repression and activation. Cell. 2014;159:647–661.
53. Hu J, Lei Y, Wong WK, et al. Direct activation of human and mouse Oct4 genes using engineered TALE and Cas9 transcription factors. Nucleic Acids Res. 2014;42:4375–4390.
54. Deaner M, Alper HS. Systematic testing of enzyme perturbation sensitivities via graded dCas9 modulation in Saccharomyces cerevisiae. Metab Eng. 2017;40:14–22.
55. Gong X, Zhang T, Xing J, et al. Positional effects on efficiency of CRISPR/Cas9-based transcriptional activation in rice plants. aBIOTECH. 2020;1:1–5.
56. Chavez A, Tuttle M, Pruitt BW, et al. Comparison of Cas9 activators in multiple species. Nat Methods. 2016;13:563–567.
57. Lin S, Ewen-Campen B, Ni X, et al. In vivo transcriptional activation using CRISPR/Cas9 in drosophila. Genetics. 2015;201:433–442.
58. Fu Y, Foden JA, Khayter C, et al. High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat Biotechnol. 2013;31:822–826.
59. Pattanayak V, Lin S, Guilinger JP, et al. High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity. Nat Biotechnol. 2013;31:839–843.
60. Papikian A, Liu W, Gallego-Bartolome J, et al. Site-specific manipulation of Arabidopsis loci using CRISPR-Cas9 SunTag systems. Nat Commun. 2019;10:729.
61. Norman TM, Horlbeck MA, Replogle JM, et al. Exploring genetic interaction manifolds constructed from rich single-cell phenotypes. Science. 2019;365:786–793.
62. Liu Y, Yu C, Daley TP, et al. CRISPR activation screens systematically identify factors that drive neuronal fate and reprogramming. Cell Stem Cell. 2018;23:758–771 e758.
63. Boettcher M, Tian R, Blau JA, et al. Dual gene activation and knockout screen reveals directional dependencies in genetic networks. Nat Biotechnol. 2018;36:170–178.
64. Yang J, Rajan SS, Friedrich MJ, et al. Genome-Scale CRISPRa Screen Identifies Novel Factors for Cellular Reprogramming. Stem Cell Reports. 2019;12:757–771.
65. Joung J, Engreitz JM, Konermann S, et al. Genome-scale activation screen identifies a lncRNA locus regulating a gene neighbourhood. Nature. 2017;548:343–346.
66. Chong ZS, Ohnishi S, Yusa K, et al. Pooled extracellular receptor-ligand interaction screening using CRISPR activation. Genome Biol. 2018;19:205.
67. Ramkumar P, Kampmann M. CRISPR-based genetic interaction maps inform therapeutic strategies in cancer. Transl Cancer Res. 2018;7:S61-S67.
68. Horlbeck MA, Gilbert LA, Villalta JE, et al. Compact and highly active next-generation libraries for CRISPR-mediated gene repression and activation. Elife. 2016;5.
69. Sanson KR, Hanna RE, Hegde M, et al. Optimized libraries for CRISPR-Cas9 genetic screens with multiple modalities. Nat Commun. 2018;9:5416.
70. Braun CJ, Bruno PM, Horlbeck MA, et al. Versatile in vivo regulation of tumor phenotypes by dCas9-mediated transcriptional perturbation. Proc Natl Acad Sci U S A. 2016;113:E3892–E3900.
71. Wangensteen KJ, Wang YJ, Dou Z, et al. Combinatorial genetics in liver repopulation and carcinogenesis with a in vivo CRISPR activation platform. Hepatology. 2018;68:663–676.
72. Zhou H, Liu J, Zhou C, et al. In vivo simultaneous transcriptional activation of multiple genes in the brain using CRISPR-dCas9-activator transgenic mice. Nat Neurosci. 2018;21:440–446.
73. Schoger E, Carroll KJ, Iyer LM, et al. CRISPR-mediated activation of endogenous gene expression in the postnatal heart. Circ Res. 2020;126:6–24.
74. Wang G, Chow RD, Bai Z, et al. Multiplexed activation of endogenous genes by CRISPRa elicits potent antitumor immunity. Nat Immunol. 2019;20:1494–1505.
75. Hsu MN, Huang KL, Yu FJ, et al. Coactivation of endogenous Wnt10b and Foxc2 by CRISPR activation enhances BMSC osteogenesis and promotes calvarial bone regeneration. Mol Ther. 2020;28:441–451.
76. Matharu N, Rattanasopha S, Tamura S, et al. CRISPR-mediated activation of a promoter or enhancer rescues obesity caused by haploinsufficiency. Science. 2019;363.
77. Ewen-Campen B, Yang-Zhou D, Fernandes VR, et al. Optimized strategy for in vivo Cas9-activation in Drosophila. Proc Natl Acad Sci U S A. 2017;114:9409–9414.
78. Jia Y, Xu RG, Ren X, et al. Next-generation CRISPR/Cas9 transcriptional activation in Drosophila using flySAM. Proc Natl Acad Sci U S A. 2018;115:4719–4724.
79. Zirin J, Hu Y, Liu L, et al. Large-scale transgenic drosophila resource collections for loss- and gain-of-function studies. Genetics. 2020;214:755–767.
80. Long L, Guo H, Yao D, et al. Regulation of transcriptionally active genes via the catalytically inactive Cas9 in C. elegans and D. rerio. Cell Res. 2015;25:638–641.
81. Lowder LG, Zhang D, Baltes NJ, et al. A CRISPR/Cas9 Toolbox for multiplexed plant genome editing and transcriptional regulation. Plant Physiol. 2015;169:971–985.
82. Park JJ, Dempewolf E, Zhang W, et al. RNA-guided transcriptional activation via CRISPR/dCas9 mimics overexpression phenotypes in Arabidopsis. PLoS One. 2017;12:e0179410.
83. Lee JE, Neumann M, Duro DI, et al. CRISPR-based tools for targeted transcriptional and epigenetic regulation in plants. PLoS One. 2019;14:e0222778.
84. Lowder LG, Zhou J, Zhang Y, et al. Robust transcriptional activation in plants using multiplexed CRISPR-Act2.0 and mTALE-Act Systems. Mol Plant. 2018;11:245–256.
85. Jensen ED, Ferreira R, Jakociunas T, et al. Transcriptional reprogramming in yeast using dCas9 and combinatorial gRNA strategies. Microb Cell Fact. 2017;16:46.
86. Lian J, HamediRad M, Hu S, et al. Combinatorial metabolic engineering using an orthogonal tri-functional CRISPR system. Nat Commun. 2017;8:1688.
87. Maselko M, Feltman N, Upadhyay A, et al. Engineering multiple species-like genetic incompatibilities in insects. Nat Commun. 2020;11:4468.
88. Selma S, Bernabe-Orts JM, Vazquez-Vilar M, et al. Strong gene activation in plants with genome-wide specificity using a new orthogonal CRISPR/Cas9-based programmable transcriptional activator. Plant Biotechnol J. 2019;17:1703–1705.

Information & Authors

Information

Published In

cover image The CRISPR Journal
The CRISPR Journal
Volume 3Issue Number 5October 2020
Pages: 350 - 364
PubMed: 33095045

History

Published online: 20 October 2020
Published in print: October 2020

Permissions

Request permissions for this article.

Topics

Authors

Affiliations

J. Armando Casas-Mollano
Department of Biochemistry, Molecular Biology, and Biophysics, BioTechnology Institute, University of Minnesota, Twin-Cities, Saint Paul, Minnesota, USA; and Cell Biology, and Development, University of Minnesota, Twin-Cities, Saint Paul, Minnesota, USA.
Matthew H. Zinselmeier
Department of Genetics, Cell Biology, and Development, University of Minnesota, Twin-Cities, Saint Paul, Minnesota, USA.
Samuel E. Erickson
Department of Biochemistry, Molecular Biology, and Biophysics, BioTechnology Institute, University of Minnesota, Twin-Cities, Saint Paul, Minnesota, USA; and Cell Biology, and Development, University of Minnesota, Twin-Cities, Saint Paul, Minnesota, USA.
Michael J. Smanski* [email protected]
Department of Biochemistry, Molecular Biology, and Biophysics, BioTechnology Institute, University of Minnesota, Twin-Cities, Saint Paul, Minnesota, USA; and Cell Biology, and Development, University of Minnesota, Twin-Cities, Saint Paul, Minnesota, USA.

Notes

*
Address correspondence to: Michael J. Smanski, PhD, Department of Biochemistry, Molecular Biology, and Biophysics, BioTechnology Institute, University of Minnesota, Twin-Cities, 1479 Gortner Ave., Room 140, Saint Paul, MN 55108, USA, [email protected]

Author Disclosure Statement

No competing financial interests exist.

Funding Information

J.A.C.M. and M.J.S. are part of a team supported by the Advanced Plant Technologies program, DARPA Award HR001118C0146. M.H.Z. is supported by an NIH NIGMS Biotechnology Training grant NIHT32GM008347.

Metrics & Citations

Metrics

Citations

Export citation

Select the format you want to export the citations of this publication.

View Options

Get Access

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.

Society Access

If you are a member of a society that has access to this content please log in via your society website and then return to this publication.

Restore your content access

Enter your email address to restore your content access:

Note: This functionality works only for purchases done as a guest. If you already have an account, log in to access the content to which you are entitled.

View options

PDF/EPUB

View PDF/ePub

Full Text

View Full Text

Media

Figures

Other

Tables

Share

Share

Copy the content Link

Share on social media

Back to Top